"renal carcinoma" trang 2 - tải miễn phí từ tailieuXANH
Sorafenib as a second-line treatment in metastatic renal cell carcinoma in Mexico: A prospective cohort study

Sorafenib as a second-line treatment in metastatic renal cell carcinoma in Mexico: A prospective cohort study
9    35    1
Knockdown of NSD2 suppresses renal cell carcinoma metastasis by inhibiting epithelial-mesenchymal transition

Knockdown of NSD2 suppresses renal cell carcinoma metastasis by inhibiting epithelial-mesenchymal transition
8    43    0
The role of YB1 in renal cell carcinoma cell adhesion

The role of YB1 in renal cell carcinoma cell adhesion
8    71    0
The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions

The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions
6    46    0
Changes in therapy and survival of metastatic renal cell carcinoma in Estonia

Changes in therapy and survival of metastatic renal cell carcinoma in Estonia
7    70    0
Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: Pooled subgroup analysis from the randomized, COMPARZ studies

Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: Pooled subgroup analysis from the randomized, COMPARZ studies
8    43    0
Ubiquitin-specific protease-44 inhibits the proliferation and migration of cells via inhibition of JNK pathway in clear cell renal cell carcinoma

Ubiquitin-specific protease-44 inhibits the proliferation and migration of cells via inhibition of JNK pathway in clear cell renal cell carcinoma
12    55    0
Stem/progenitor cell marker expression in clear cell renal cell carcinoma: A potential relationship with the immune microenvironment to be explored

Stem/progenitor cell marker expression in clear cell renal cell carcinoma: A potential relationship with the immune microenvironment to be explored
10    84    0
Intratumoural renal cell carcinoma haemorrhage following stereotactic radiotherapy: A case report

Intratumoural renal cell carcinoma haemorrhage following stereotactic radiotherapy: A case report
5    47    0
Pazopanib has equivalent anti-tumor effectiveness and lower Total costs than Sunitinib for treating metastatic or advanced renal cell carcinoma: A metaanalysis

Pazopanib has equivalent anti-tumor effectiveness and lower Total costs than Sunitinib for treating metastatic or advanced renal cell carcinoma: A metaanalysis
12    52    0
Collagen organization of renal cell carcinoma differs between low and high grade tumors

Collagen organization of renal cell carcinoma differs between low and high grade tumors
8    63    0
Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database

Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database
15    44    0
Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma

Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma
12    61    0
Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: A retrospective analysis

Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: A retrospective analysis
13    68    0
Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma

Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma
9    59    0
UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma

UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma
11    57    0
Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma

Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma
10    58    0
Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma

Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma
8    85    0
Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma

Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma
12    77    0
Pathologic analysis of non-neoplastic parenchyma in renal cell carcinoma: A comprehensive observation in radical nephrectomy specimens

Pathologic analysis of non-neoplastic parenchyma in renal cell carcinoma: A comprehensive observation in radical nephrectomy specimens
7    99    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.